col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


231 Results       Page 1

 [1] 
Elsevier: Clinica Chimica Acta
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―20 Blood proteomics in COVID-19 infection: An update Michal Alexovič, Tetiana Bondarchuk, Csilla Uličná, Ján Sabo
2 [GO] 2024―May―15 Monitoring coronavirus disease progression and clinical impact through quantitative viral load testing Chih-Kai Chang, Chi-Sheng Chen, Ming-Jr Jian, Hsing-Yi Chung, Feng-Yee Chang, Jung-Chung Lin, et al. (+6)
3 [GO] 2024―May―08 Comparison of changes in liver function tests in pregnant women with mild and severe COVID-19 R. Hosseiniara
4 [GO] 2024―May―08 Vitamin D and immune resilience in the context of COVID-19 A.H. Ghrieb
5 [GO] 2024―May―08 Characteristics of micronutrient intake in symptomatic and asymptomatic outpatients infected with COVID-19 L.E. Herrera-Jiménez, H.R. Ceja-Gálvez, J.F. Muñoz-Valle, C.J. Baños-Hernández, G. Macedo-Ojeda, G. González-Estevez
6 [GO] 2024―May―08 Drug-drug liver injury in patients NAFLD with COVID-19 A. Pavlov, A. Karakozov, A. Molodova, O. Denisova, S. Kazakov
7 [GO] 2024―May―08 Serum non-invasive liver fibrosis markers in patients with COVID-19 B. Cylwik, E. Gruszewska, B. Zelazowska-Rutkowska, M. Kazberuk, K. Gan, M. Kralisz, et al. (+2)
8 [GO] 2024―May―08 The study of the level of interleukin-6 and gamma interferon in patients with COVID-19 N. Davydova, S. Putkov, S. Kazakov
9 [GO] 2024―May―08 Laboratory indicators of inflammation in the development of cytokine storm in patients with COVID-19 S. Putkov, N. Davydova, S. Kazakov
10 [GO] 2024―May―08 Analysis of CD95 ligand on post COVID-19 patient: A novel approach to understand apoptosis role in long-term effect of COVID-19 M. Justyn, T. Yulianti, W. Gofarana
11 [GO] 2024―May―08 The connection of Vitamin D concentration with hematological parameters in patients with COVID-19 M. Stanojevic Pirkovic, T. Cvetkovic, I. Nikolic, M. Andjelkovic, S. Zivancevic Simonovic, B. Babovic, et al. (+7)
12 [GO] 2024―May―08 The connection of vitamin D with biomarkers of systemic inflammation in patients with COVID-19 O. Mihaljevic, S. Zivancevic Simonovic, V. Jurisic, B. Babovic, J. Djordjevic, D. Jovanovic, et al. (+3)
13 [GO] 2024―May―08 The significance of hypovitamin D in the development of heart failure in patients with COVID-19 O. Mihaljevic, S. Zivancevic Simonovic, V. Jurisic, B. Babovic, J. Djordjevic, D. Jovanovic, et al. (+4)
14 [GO] 2024―May―08 The connection of hypovitaminose D and biomarkers of acute coronary syndrome in patients with COVID-19 M. Stanojevic Pirkovic, M. Andjelkovic, S. Zivancevic Simonovic, M. Petrovic, I. Nikolic, M. Kostic, et al. (+7)
15 [GO] 2024―May―08 Distance changes of lymphocyte quantity and function in patients with COVID-19 S. Sołomacha, A. Moniuszko-Malinowska, P. Sowa, Ł. Kiszkiel, P. Laskowski, M. Alimowski, et al. (+2)
16 [GO] 2024―May―08 Correlation of hepatocyte growth factor (HGF) and high sensitivity C-reactive protein (hs-CRP) in long-term COVID-19 B. Zaira, T. Yulianti, J. Levita
17 [GO] 2024―May―08 Serum galectin-9 concentration in patients with COVID-19 E. Gruszewska, M. Kralisz, B. Cylwik, M. Kazberuk, K. Gan, B. Mroczko, et al. (+2)
18 [GO] 2024―May―08 Procalcitonin and transferrin as a survival markers of patients with COVID-19 L. Chrostek, K. Gan, M. Kazberuk, M. Kralisz, E. Gruszewska, A. Panasiuk, B. Cylwik
19 [GO] 2024―May―08 Evaluation of laboratory parameters of hospitalized patients with COVID-19 C. Sgura, A.E. State, C. Cercel, S.G. Chiran, T.S. Holban, F. Romanoschi, et al. (+2)
20 [GO] 2024―May―08 Interferon gamma and Interleukin 8 in COVID-19 F. Mechi, M. Ghozzi, S. Melayah, M. Taamalia, I. Ghedira
21 [GO] 2024―May―08 Kinetics of KL-6 may predict lung scarring after severe COVID-19 N. De Vos, M. Bruyneel, A. Roman, M. Antoine, F. Cotton
22 [GO] 2024―May―08 Spectrum of bacterial infection in COVID-19 and possibilities of antimicrobial therapy N. Esaulenko, O. Tkachenko, K. Komur, S. Kazakov
23 [GO] 2024―May―08 COVID-19 and susceptibility genes: A possible implication of the C-C type chemokine receptor 5 polymorphism R. Kerek, B. Alshaikh Khaled
24 [GO] 2024―May―08 Blood donation and seroprevalence of covid-19 antibodies among blood donors at central blood bank, Palestine R. Abu Seir, K. Yasin, L. Nazzal, O. Najjar
25 [GO] 2024―May―08 The emergence of SARS-COV-2 variant(s) and its impact on the prevalence of COVID-19 cases in the Nabatieh Region, Lebanon F.Y. Noureddine, M. Chakkour, A. El Roz, J. Reda, R. Al Sahily, A. Assi, et al. (+6)
26 [GO] 2024―May―08 Serologic profile of individuals who contracted COVID-19 despite triple vaccination S. El Hawat, P. Finianos, S. Yaacoub, M. Germanos Haddad, C. Haddad
27 [GO] 2024―May―08 Prevention of COVID-19 development in patients with hematological pathology receiving monoclonal antibody therapy E. Ignateva, O. Rukavitsyn, S. Kazakov
28 [GO] 2024―May―08 Identification of immunoreactive COVID-19 epitopes based on M13 phage display library T. Shabana, I. Abbasi, R. Abu Helu, H. Alkhatib
29 [GO] 2024―May―08 Clinical manifestations of rhinovirus infections during the latest wave of COVID-19 in hospitalized children O. Zaibi, Y. Maatouk, I. Baccouche, I. Handous, M. Marzouk, N. Hannachi, J. Boukadida
30 [GO] 2024―May―08 Alpha-defensins: Risk factor for thrombosis in COVID-19 infection S. Abdeen, R. Abu-Fanne, E. Maraga, N. Khurram, S. Samuel Heyman, D. Cines, A. Al-Roof Higazi
31 [GO] 2024―May―08 Persistence of T cell immunity responses against SARS-COV-2 for over 12 months post COVID-19 infection in unvaccinated convalescent individuals with no detectable IGG antibodies V. Pitiriga, M. Papamentzelopoulou, K. Konstantinakou, I. Vasileiou, K. Sakellariou, A. Tsakris
32 [GO] 2024―May―08 COVID-19 infection: a review of hematological and morphological features A.D. Amoroso, S. Bongo, S. Bernardini, G. Adorno, R. Massoud, M. Morello
33 [GO] 2024―May―08 GGT level as a new biomarker of COVID-19 infection; A systematic review and meta-analysis comparing intensive care unit(ICU) patients with non- ICU cases M. Tahani, S. Rakhshani Nasab, I. Shahramian, M. Afshari, H. Mirzaei, F. Parooie, M. Salarzaei
34 [GO] 2024―May―08 Mild-to-moderate COVID-19 may affect nervous system function in convalescents M. Lulek, M. Malecka-Gieldowska, O. Ciepiela
35 [GO] 2024―May―08 Epidemiological study: Evolution of septicemia deaths in Brazil (2017-2022) in the face of the COVID-19 Pandemic M. Danda Vasconcelos Santos, K. Silva Souza, M.R. Freire Da Silva, M. Almeida Candido, F. Motteran, L.C. Alexandre De Araújo, M.B. Melo De Oliveira
36 [GO] 2024―May―08 Assessment of d-dimer concentrations determined in outpatients in a selected medical laboratory during the covid-19 pandemic (2020-2022) S. Myslicki, P. Cembrowska, J. Sikora
37 [GO] 2024―May―08 How did the COVID-19 pandemic impact drug trends? G. García De La Rosa, R. Pérez Rodríguez, C. Frías Ruiz, C. Burruezo Rodríguez, S. De Las Heras Flórez
38 [GO] 2024―May―08 The essential role of volunteer biologists in Lebanon’s COVID-19 pandemic management efforts M. Germanos, N. Banna, Z. Berjaoui, N. Bizri, P. Finianos, H. Hassan, et al. (+7)
39 [GO] 2024―May―08 Oxidative stress severity’s as a hallmark in the COVID-19 patients A.H. Doustimotlagh, N. Roustaei, M. Eftekhari, A. Bastin
40 [GO] 2024―May―08 Significance of leukogram-derived indices (NLR, LMR and NER) in the monitoring of COVID-19 patients L. Halilovic, E. Begovic, E. Sehercehajic, B. Hasanefendic, S. Hajro, S. Muhovic, et al. (+2)
41 [GO] 2024―May―08 Correlation of specific inlammatory and coagulation parameters among COVID-19 patients B. Hasanefendic, A. Husic-Selimovic, E. Sehercehajic, L. Halilovic, S. Tihic-Kapidzic, J. Foco-Solak, et al. (+2)
42 [GO] 2024―May―08 Growth differentiation factor 15 (GDF-15) as a predictor of mortality in COVID-19 patients S. Mandić, L. Švitek, I. Lukić, T. Rolić, B. Grubišić, M. Zlosa, Z. Todorić
43 [GO] 2024―May―08 Rotational thromboelastometry (CLORPRO) profiling of COVID-19 patients I. Rodriguez Martin, J. Montenegro Martínez, J.L. Rubio Prieto, J.M. Guerrero MontÁvez
44 [GO] 2024―May―08 The biomarkers of oxidative stress - An effective tool for diagnosing COVID-19 patients and convalescents B. Wolszczak-Biedrzycka, J. Dorf, J. Matowicka-Karna, M. Wojewódzka-Żeleźniakowicz, A. Zalewska, M. Maciejczyk
45 [GO] 2024―May―08 Prevalence of serum TnI elevation among COVID-19 patients at Kenyatta National Hospital, Kenya T. Kaugiria, A. Amayo, M. Mungania
46 [GO] 2024―May―08 Prevalence of serum TnI elevation among COVID-19 patients at KNH, Kenya A. Kaugiria
47 [GO] 2024―May―08 Superinfections in COVID-19 patients hospitalized in intensive care unit (ICU): Risk factors and mortality Z. Hammami, Y. Ben Lamine, S. Kaoual, O. Nasri, A. Trabelsi, O. Kaabachi, S. Bebes
48 [GO] 2024―May―08 Prediction of atherosclerosis in severe COVID-19 patients with CD16 and CD18 markers and inflammatory factors R. Mardani, M. Shahali
49 [GO] 2024―May―08 IVDR performance study of angiotensine-1-7, TGF-beta and KL-6 for COVID-19 sequela N. De Vos, M. Antoine, M. Bruyneel, A. Roman, F. Cotton
50 [GO] 2024―May―08 Predictive value of ferritin, IL-6, and erythropoietin in assessment of COVID-19 severity K. Gugo, L. Rumora, M. Pavicic Ivelja, L. Tandara
51 [GO] 2024―May―08 Interleukin 8 but not interferon gamma is predictive of COVID-19 severity: A tunisian study F. Mechi, M. Ghozzi, S. Melayah, M. Taamalia, I. Ghedira
52 [GO] 2024―May―08 Machine learning-based prediction of intensive care during hospitalization for COVID-19 using laboratory test results at admission H. Lame, E. Refatllari, N. Heta, I. Korita, A. Coraj, V. Tole, A. Bulo
53 [GO] 2024―May―08 Prospective evaluation of the likelihood of vaxzevria-induced thrombosis among nigerian healthcare workers undergoing COVID-19 vaccination C. Amadi, D.L. Stephenson
54 [GO] 2024―May―08 Vaccine uptake, barriers and enhancers of COVID-19 vaccination among health care workers in Ethiopia G. Bulti, D. Asfaw, S. Abdella, J. Bulti Tura, Y. Wondarad, G. Fetensa, et al. (+14)
55 [GO] 2024―May―08 Two years after MRNA COVID-19 vaccination anti-spike SARS-COV-2 antibodies persist at high concentrations, due to boosters administration and natural contact with the virus J. Swadzba, T. Anyszek, E. Martin, A. Panek
56 [GO] 2024―May―08 Unraveling the impact of COVID-19 vaccination on hospital stay, ICU admission and mortality: A real world evidence from Pakistan N. Afzal
57 [GO] 2024―May―08 Assessment of COVID-19 vaccine immunogenicity over one year in patients receiving immunomodulators/immunosuppressants or polychemotherapy S. Kouara, Z. Lebbar, K. Meliani, G. Yahyaoui, Z. Khammar, R. Berrady, M. Mahmoud
58 [GO] 2024―May―08 Public perception towards the COVID-19 vaccine in Riyadh, Saudi Arabia Z. Kurdee, S. Al-Shouli, N. Alafaleq, S. Ayoub Meo, A. Alshahrani, A. Alshehri, et al. (+3)
59 [GO] 2024―May―08 Calprotectin as a novel indicator of severe COVID-19: A cross-sectional study in Mexican population H.R. Ceja-Galvez, C.O. Hernández Ramírez, A.N. Vega-Magaña, K.J. Arellano-Arteaga, E. Miramontes-Luna, F.J. Turrubiates- Hernandez, et al. (+2)
60 [GO] 2024―May―08 Depletion of retinol-binding protein 4 levels in hospitalized patients with COVID-19: A potential biomarker for disease severity F.J. Turrubiates-Hernández, G. Muñoz-Ríos, C.O. Hernández-Ramírez, H.R. Ceja-Gálvez, S. García-Arellano, L.E. Herrera-Jiménez, et al. (+3)
61 [GO] 2024―May―08 Clinical performance evaluation of smartchek SARS-COV-2 detection kit and smartchek SARS-COV-2 fast detection kit for detection of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in saliva M.J. Kim, S. Yoon, S.R. Cho
62 [GO] 2024―May―08 Point of care testing for new coronavirus antigen detection (SARS-COV-2): A Critical analysis of instructions for use and degree of agreement compared to RT-PCR B. Gonçalves Carneiro, L. Vasconcellos
63 [GO] 2024―May―08 The relationship between disorders of the plasma and platelet components of hemostasis with the severity and timing of coronavirus infection in patients with chronic coronary syndromes V. Sujayeva, I. Karpova, M. Kolyadko, O. Koshlataya, I. Russkich
64 [GO] 2024―May―08 One-pot isothermal amplification and CRISPR-CAS12A assay for rapid detection of SARS-COV-2 S. Tang, S. Qian, H. Lin, B. Li, X. Deng, H. Chen
65 [GO] 2024―May―08 Detection and comparison of SARS-COV-2 antibody produced in naturally infected and vaccinated patients in Addis Ababa, Ethiopia C. Bashea, F. Challa, T. Lejisa, S. Ali, G.B. Hundie, H.H. Tola, et al. (+2)
66 [GO] 2024―May―08 Evaluation of the diagnostic performance of the sofia 2 SARS CoV2 system in the detection of SARS-CoV-2 antigen in POCT: An analysis of 130 samples V. Lombari, E. Esposito, V. Proietti, S. Sgueglia, L.A. Catapane, A. Terracciano, et al. (+3)
67 [GO] 2024―May―08 Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-COV-2 breakthrough infection: Results from the cov-adapt cohort M. Schnelle, S. Dierks, M. Hollstein, M. Schön, U. Groß, A. Kröger, et al. (+3)
68 [GO] 2024―May―08 Circulating CD4+ T lymphocyte helper cells confer protection to reinfection of SARS-COV-2 but not circulating CD8+ T Lymphocyte natural killer cells J. Donnelly, L. Abdelwareth, F. Al Hosani, R. Abuyadek, R. Al-Rifia, S. Atef
69 [GO] 2024―May―08 The increased sensitivity of the Xpert® Xpress assay in detecting SARS-COV-2, compared to the COBAS® assay, can be attributed to the nucleocapsid gene target B. Ayano, A. Alemu, S. Gebre-Selassie, H. Kebede, W. Abegaz
70 [GO] 2024―May―08 AI unravels dual-targeting mechanism: Crafting potential inhibitors for SARS-CoV-2 design R. Hamdy
71 [GO] 2024―May―08 Optimization between reagent use efficiency and analytical sensitivity for a reliable pool-based strategy of SARS-COV-2 detection J.P. Miranda, J. Osorio, M. Silva, C. Silva, M. Henríquez-Henríquez
72 [GO] 2024―May―08 Results of the external quality assessment (EQA) scheme for serological diagnostic test for SARS-CoV-2 detection in Sicily region (Italy), in 2020-2022 F. Di Gaudio, G. Brunacci, O. Aiello, V. Buffa, V. Orlando, F. Centineo, et al. (+5)
73 [GO] 2024―May―08 Follow-up and comparative assessment of SARS-COV-2 IGA, IGG, neutralizing, and total antibody responses after BNT162B2 or MRNA-1273 heterologous booster vaccination S. Younes, E. Nicolai, M. Pieri, B. Sergio, H.I. Daas, D.W. Al-Sadeq, et al. (+9)
74 [GO] 2024―May―08 Assessment of humoral and cellular immunity to SARS-COV-2 in end-stage renal disease patients treated with haemodialysis D. Cujic, A. Todorovic, M. Gnjatovic, E. Jordanova, M. Stajcic, R. Markovic, T. Jemcov
75 [GO] 2024―May―08 Machine learning algorithms for identification of SARS-CoV-2 in neonates D. Dobrijević, J. Katanić, K. Pastor
76 [GO] 2024―May―08 The association between polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 AND TNF< genes with susceptibility and severity of SARS-COV-2 infection V. Pecoraro, M. Cuccorese, T. Trenti
77 [GO] 2024―May―08 In silico screening of potential SARS-COV-2 MAIN protease inhibitors from thymus Schimperi H.M. Mengist, K. Zunera, A. Fentahun
78 [GO] 2024―May―08 Quality and composition of archived nucleic acids after use in SARS-COV-2 molecular testing J.W. Shin, J. Kim, H.H. Song, J.C. Choi, R. Lee, S.K. Yoon, et al. (+2)
79 [GO] 2024―May―08 Performance of novel SARS-COV-2 rapid antigen tests during omicron outbreak compared with Omicron RT-PCR and whole-genome sequencing S. Kim, W. Choi
80 [GO] 2024―May―08 Stable preservation of SARS-COV-2 RNA from gargle samples on FTA cards G. Kriegshäuser, A. Berndt, D. Alpar, C. Oberkanins
81 [GO] 2024―May―08 SARS-COV-2 seroprevalence and risk factors associated with infection in adults from western Romania, January to March 2023 T.R. Olariu, A.C. Craciun, D.C. Vlad, V. Dumitrascu, M.A. Lupu
82 [GO] 2024―May―08 Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-COV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter G. Nasrallah, F. Ali, S. Younes, H.M. Yassine
83 [GO] 2024―May―08 Persistence of SARS-COV-2-specific T cell responses for over 12 months in vaccinated population with no measurable levels of anti-S antibodies V. Pitiriga, M. Papamentzelopoulou, K. Konstantinakou, I. Vasileiou, A. Tsakris
84 [GO] 2024―May―08 Natural infection versus hybrid (natural and vaccination) humoral immune response to SARS-COV-2: A comparative paired analysis L. Abdelwareth, F. Alhousani, R. Abuyadek, J. Donnelly, A. Leinberger-Jabari, S. Atef, R.H. Al-Rifai
85 [GO] 2024―May―08 Pediatric multisystemic inflammatory syndrome associated to SARS-Cov2 I. Mezghani, M. Turki, A. Elleuch, F. Ayedi
86 [GO] 2024―May―08 Epidemiology of respiratory viruses (Excluding SARS-COV2) at the military hospital of instruction mohammed v (HMIMV) of rabat: Retrospective study over a period of 44 month (SEPTEMBER 2019 - APRIL 2023) R. Tagajdid
87 [GO] 2024―May―08 Frequency of carbapenem resistant providencia stuartii isolation from clinical samples in relation to colistin consumption in the ICU of a tertiary hospital before and during the pandemic (2019-2022) C. Zarras, K. Zarras, E. Christou, A. Pyrpasopoulou, C. Michailidou, K. Mpani, et al. (+3)
88 [GO] 2024―May―08 Determination of direct oral anticoagulant in the emergency laboratory: The experience in pandemic and post-pandemic period C. Scarone, v. Dovere, c. Traverso, f. Lillo
89 [GO] 2024―May―08 Comparative analysis of global regulations for IVDs in the pandemic situation M.S. Noh
90 [GO] 2024―Jan―05 Evaluation of diagnostic performance of SARS-CoV-2 infection using digital droplet polymerase chain reaction in individuals with or without COVID-19 symptoms Yoonjung Kim, Eunyoung Lee, Boyeon Kim, Jinhee Cho, Sook-Won Ryu, Kyung-A Lee
91 [GO] 2024―Jan―04 Quality and composition of archived nucleic acids after use in SARS-CoV-2 molecular testing Ho Hyun Song, Jong Cheul Choi, Ran Lee, Sook Kyung Yoon, Hye Jeong Park, Young Hee Shin, et al. (+2)
92 [GO] 2023―Nov―30 Longitudinal Impact of COVID-19 Pandemic on the Utilization of Hemoglobin A1c Testing in Outpatients Li Zha, Sara MacLeod, Tanzy Love, Robert J. Fortuna, Y. Victoria Zhang
93 [GO] 2023―Oct―21 Plasma SARS-CoV-2 N antigen is a powerful molecular marker for early detection of severe COVID-19 in patients and monitoring disease progression Xiaoyan Teng, Liuping Hu, Jiazhen Shen, Jiudong Hu, Xiaoyan Wu, Yuzhen Du
94 [GO] 2023―Oct―05 The possible role of quinolinic acid as a predictive marker in patients with SARS-CoV-2 Simon Michaelis, Sieglinde Zelzer, Christopher Schneider, Wolfgang J. Schnedl, Andreas Baranyi, Andreas Meinitzer, et al. (+2)
95 [GO] 2023―Aug―05 Evaluation of iron metabolism in hospitalized COVID-19 patients Thibaud Lefebvre, Anne Boutten, Celia Raulet-Bussian, Alexandre Raynor, Hana Manceau, Hervé Puy, et al. (+9)
96 [GO] 2023―Jun―03 CBPH assay for the highest sensitive detection of SARS-COV-2 in the semen Shuai-Feng Zhou, Chuan Huang, Shi-Kang Li, Xiao-Lei Long, Yu Chen, Zhi-Fei Zhan, et al. (+9)
97 [GO] 2023―May―15 Immunology of SARS-CoV-2 infection and vaccination Baoxu Lin, Linlin Cheng, Jin Zhang, Mei Yang, Yixiao Zhang, Jianhua Liu, Xiaosong Qin
98 [GO] 2023―Mar―13 Letter to the editor regarding: “A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population”. Clinica Chimica Acta 538 (2023) 211-215 Janice L. Atkins, Mitchell Lucas, Luke C. Pilling, David Melzer
99 [GO] 2023―Mar―05 Designing and developing a sensitive and specific SARS-CoV-2 RBD IgG detection kit for identifying positive human samples Ehsan Raoufi, Fatemeh Hosseini, Bahman Onagh, Mohammad Salehi-Shadkami, Marjan Mehrali, Monireh Mohsenzadegan, et al. (+6)
100 [GO] 2023―Jan―11 Time series analysis revealed prognostic value of continuous nasopharyngeal SARS-CoV-2 nucleic acid quantification for COVID-19: A retrospective study of >3,000 COVID-19 patients from 2 centers Zhiyuan Wu, Can Yang, Yutao Shen, Qingyun Zhang, Xuemei Tang, Di Wang, et al. (+14)
101 [GO] 2022―Dec―24 A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population J.A. H뫎k, T. Philipp, V. Adamkova, O. Majek, L. Dusek
102 [GO] 2022―Dec―15 Evaluation of reverse transcriptase-polymerase spiral reaction assay for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2 Sharan Prerana, Pai Ashwini, Karanth Padyana Anupama, Valakkunja Shankaranarayana Prajna, Kattapuni Suresh Prithvisagar, Ashwath Nayak, et al. (+5)
103 [GO] 2022―Nov―18 COVID-19 Diagnostics: Molecular biology to Nanomaterials Summaya Perveen, Anjali Negi, Varun Gopalakrishnan, Satyajit Panda, Vinay Sharma, Rashmi Sharma
104 [GO] 2022―Oct―29 Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection Lucia Salvioni, Filippo Testa, Adela Sulejmani, Francesca Pepe, Pietro Giorgio Lovaglio, Paolo Berta, et al. (+6)
105 [GO] 2022―Oct―21 Alteration of the kynurenine pathway is inversely associated with the humoral immune response in patients with SARS-CoV-2 Simon Michaelis, Sieglinde Zelzer, Christopher Schneider, Wolfgang J. Schnedl, Andreas Baranyi, Andreas Meinitzer, et al. (+2)
106 [GO] 2022―Oct―10 Salivary proteomic analysis in asymptomatic and symptomatic SARS-CoV-2 infection: innate immunity, taste perception and FABP5 proteins make the difference Ada Aita, Ilaria Battisti, Nicole Contran, Serena Furlan, Andrea Padoan, Cinzia Franchin, et al. (+6)
107 [GO] 2022―Sep―17 Angiotensin-converting enzyme 1 and voltage-gated potassium channel-interacting protein 4 gene polymorphisms in COVID-19 patients from East of Iran Hamid Abbaszadeh, Fariba Mohammadi, Mahdieh Rajabi-Moghaddam, Hamid Kabiri-Rad, Shokouh Ghafari, Farshid Abedi, Ebrahim Miri-Moghaddam
108 [GO] 2022―Sep―17 Miniaturized Real-Time PCR systems for SARS-CoV-2 detection at the Point-of-Care Valeria Garzarelli, Maria Serena Chiriacò, Marco Cereda, Isidora Autuori, Francesco Ferrara
109 [GO] 2022―Sep―14 Development of multiplex S-gene-targeted RT-PCR for rapid identification of SARS-CoV-2 variants by extended S-gene target failure Yuri Imaizumi, Takayuki Ishige, Tatsuki Fujikawa, Akiko Miyabe, Shota Murata, Kenji Kawasaki, et al. (+4)
110 [GO] 2022―Aug―18 Covid-19 and adolescent acute kidney injury: Renal recovery with combined enalapril and estrogen therapy E Scott Sills, Samuel H Wood, Anthony P H Walsh
111 [GO] 2022―Jun―14 Elucidation of Correlation Between SARS-CoV-2 RdRp and N Gene Cycle Threshold (Ct) by RT-PCR with Age and Gender Mati Ur Rehman, Syed Sajjad Naqvi, Rooh Ullah, Narmeen Arshad, Muhammad Ammad, Qurat Ul Ain, et al. (+4)
112 [GO] 2022―Jun―10 M193 Clinical performance of the standard F COVID-19 AG FIA for the detection of SARS-COV-2 infection S. Jirungda, P. Khamphrom, K. Klaprajun, T. Prachakul, J. Kraisin
113 [GO] 2022―Jun―10 T125 impact of the Covid-19 crisis on the point-of-care blood gases management in an ISO 22870 accredited laboratory in Paris (France) M. Vaubourdolle, B. Beneteau-Burnat, C. Aussel, P. Pernet
114 [GO] 2022―Jun―10 M125 Simulation models to predict biochemistry test capacity in Covid-19 pandemic surge capacity planning in tertiary care centres B. Kyle, A. Bajkov, D. Haugrud, F. Wu, A. Lyon, M. Lyon
115 [GO] 2022―Jun―10 W097 Usefulness of urine biomarkers for the prediction of in-hospital mortality in the COVID-19 patients D. Morell-Garcia, D. Ramos-Chavarino, J.M. Bauça, P. Argente Del Castillo, M.A. Ballesteros-Vizoso, B. García, et al. (+5)
116 [GO] 2022―Jun―10 W182 Association between nutritional and inflammatory biomarkers in COVID-19 patients with chronic kidney disease V. Khurana, B. Goswami, S. Kaushik
117 [GO] 2022―Jun―10 T259 Evaluation of coagulation function in critically ill patients with severe Covid-19 pneumonia I. RodrÍguez MartÍn, J. Montenegro Martinez, D. Nuñez Jurado
118 [GO] 2022―Jun―10 T256 Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe Covid-19 Pneumonia I. RodrÍguez MartÍn, J. Montenegro Martinez, M. Santana Morales, J.M. Guerrero Montávez
119 [GO] 2022―Jun―10 T222 Screening for Covid-19 with cellular morphometric parameters on the routine hematology analyzer DXH 800 M. Vasse, M. Ballester, D. Ayaka, D. Sukhachev, F. Delcominette, E. Sukhacheva, et al. (+4)
120 [GO] 2022―Jun―10 W137 Comparison of two RT PCR methods with two different genes for detection of severe acute respiratory syndrome coronavirus 2 (SARS-COV2) M. Alabdullatif, A. Hazizi, A. Alsadoon, F. Albloui, Y. Hawsawi, F. Alseraye, W. Tamimi
121 [GO] 2022―Jun―10 W124 Comparison of two RT PCR methods with two different genes for detection of severe acute respiratory syndrome coronavirus 2 (SARS-COV2) M. Alabdullatif, A. Hazizi, A. Alsadoon, F. Albloui, Y. Hawsawi, F. Alseraye, W. Tamimi
122 [GO] 2022―Jun―10 W102 Correlation between the atellica SARS-COV-2 IGG assay results and the presence of SARS-COV-2 neutralizing antibodies J. Bedini, X. Filella, S. Hidalgo, C. Gonzalez-Escribano
123 [GO] 2022―Jun―10 T102 Has the SARS-COV-2 pandemic affected cardiovascular risk parameters in the general population? M. Chlabicz, J. Jamiołkowski, A. Szum-Jakubowska, P. Sowa, M. Dubatówka, M. Łapińska, et al. (+7)
124 [GO] 2022―Jun―10 W101 Stable preservation of SARS-COV-2 RNA from gargle samples on FTA cards G. Kriegshäuser, A. Berndt, D. Alpar, C. Oberkanins
125 [GO] 2022―Jun―10 M278 Serological antibody response to SARS-COV-2 vaccination in a large cohort of Canadian children, adolescents, and adults M.K. Bohn, S. Wilson, K. Adeli
126 [GO] 2022―Jun―10 M090 Interleukine 6 is associated with severity and poor outcome in ICU-patients with SARS-CoV-2 infection N. Mario, J. Lavillegrand, M. Garnier, A. Spaeth, T. Urbina, Y. Chantran, et al. (+4)
127 [GO] 2022―Jun―08 T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cells Chang Chu, Anne Schönbrunn, Saban Elitok, Florian Kern, Karsten Schnatbaum, Holger Wenschuh, et al. (+4)
128 [GO] 2022―Jun―06 A 14+7 day quarantine period and a dual nucleic acid testing reagent strategy detect potentially indiscoverable Coronavirus disease 2019 infections in Xiamen, China Yong-Jing Wang, Jian-Hang Xue, Zan-Xi Fang, Jia-Wen Xie, Jian-Jun Niu, Tian-Ci Yang, Li-Rong Lin
129 [GO] 2022―Jun―02 At-admission HbA1c levels in Hospitalized COVID-19 Participants With and Without Known Diabetes Andrea Valle, Javier Rodriguez, Félix Camiña, Miguel A Martínez-Olmos, Juan B Ortola, Santiago Rodriguez-Segade
130 [GO] 2022―May―10 SARS-CoV-2 RNA Detection in Formalin-Fixed Paraffin-Embedded (FFPE) Tissue by Droplet Digital PCR (ddPCR) Ramanath Majumdar, Julie A. Vrana, Justin W. Koepplin, Dragana Milosevic, Anja C. Roden, Joaquin J. Garcia, et al. (+2)
131 [GO] 2022―Apr―29 Semi-nested RT-PCR enables sensitive and high-throughput detection of SARS-CoV-2 based on melting analysis Anh Thi Ngoc Nguyen, Hoai Thi Bui, Quynh Thi-Huong Pham, Ly Thi Thao Hoang, Hung Xuan Ta, Timo Heikkinen, et al. (+25)
132 [GO] 2022―Apr―09 Molecular Diagnostics of SARS-CoV-2: Findings of an International Survey Aldo Vacaflores Salinas, Tester Ashavaid, Deborah A. Payne, Mark W. Linder, Katarina Baluchova, Shiyang Pan, et al. (+2)
133 [GO] 2022―Mar―16 Tracking SARS-CoV-2 variants by entire S-gene analysis using long-range RT-PCR and Sanger sequencing Mirai Matsubara, Yuri Imaizumi, Tatsuki Fujikawa, Takayuki Ishige, Motoi Nishimura, Akiko Miyabe, et al. (+5)
134 [GO] 2022―Mar―10 Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients An Bracke, Emilie De Hert, Michelle De bruyn, Karen Claesen, Gwendolyn Vliegen, Alexandra Vujkovic, et al. (+13)
135 [GO] 2022―Feb―21 Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds Andrea Padoan, Chiara Cosma, Luisa Galla, Daniela Basso, Mario Plebani
136 [GO] 2022―Jan―05 The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients Ola Hammarsten, Pontus Ljungqvist, Björn Redfors, Mathias Wernbom, Hannes Widing, Bertil Lindahl, et al. (+6)
137 [GO] 2021―Dec―25 Answer to the letter of Lippi & Plebani entitled “Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal” Giacomo Malipiero, Danilo Villalta
138 [GO] 2021―Dec―24 Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal Giuseppe Lippi, Mario Plebani
139 [GO] 2021―Dec―14 Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types Louis Nevejan, Thomas Strypens, Mathias Van Nieuwenhove, An Boel, Lien Cattoir, Peter Meeus, et al. (+3)
140 [GO] 2021―Dec―10 Performance Verification of Five Commercial RT-qPCR Diagnostic Kits for SARS-CoV-2 Mei Yang, Shuang Cao, Yong Liu, Zhijie Zhang, Rui Zheng, Yuzhong Li, et al. (+4)
141 [GO] 2021―Dec―10 Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2 Simon Michaelis, Sieglinde Zelzer, Wolfgang J. Schnedl, Andreas Baranyi, Andreas Meinitzer, Dietmar Enko
142 [GO] 2021―Nov―27 Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2 Giacomo Malipiero, Pierlanfranco D'Agaro, Ludovica Segat, Anna Moratto, Danilo Villalta
143 [GO] 2021―Nov―12 Serum level of testosterone predicts disease severity of male COVID-19 patients and is related to T-cell immune modulation by transcriptome analysis Shufa Zheng, Qianda Zou, Dan Zhang, Fei Yu, Jiaqi Bao, Bin Lou, et al. (+9)
144 [GO] 2021―Oct―29 SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): kinetics and comparison with chemiluminescent assays Andrea Padoan, Chiara Cosma, Francesco Bonfante, Foscarina della Rocca, Francesco Barbaro, Claudia Santarossa, et al. (+7)
145 [GO] 2021―Oct―29 IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers Giulia Brisotto, Elena Muraro, Marcella Montico, Chiara Corso, Chiara Evangelista, Mariateresa Casarotto, et al. (+7)
146 [GO] 2021―Sep―29 Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy Francisco Raposo, Giuseppe Lippi
147 [GO] 2021―Sep―21 Endothelial dysfunction and Mid-Regional proAdrenomedullin: what role in SARS-CoV-2 infected Patients? Martina Zaninotto, Monica Maria Mion, Lucio Marchioro, Andrea Padoan, Mario Plebani
148 [GO] 2021―Aug―20 Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects Davide Ferrari, Nicola Clementi, Sestina Maria Spanò, Sami Albitar-Nehme, Stefania Ranno, Alessandra Colombini, et al. (+10)
149 [GO] 2021―Aug―16 Sources and clinical significance of aspartate aminotransferase increases in COVID-19 Elena Aloisio, Giulia Colombo, Claudia Arrigo, Alberto Dolci, Mauro Panteghini
150 [GO] 2021―Aug―05 Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection Heriks Gomes Ribeiro, Raquel Costa Silva Dantas-Komatsu, Jeane Franco Pires Medeiros, Maria Clara da Cruz Carvalho, Victor de Lima Soares, Bruna Zavarize Reis, et al. (+2)
151 [GO] 2021―Jul―16 A theoretical simulation of SARS-CoV-2 pooled testing: pooled sample collection outperforms pooled RNA extraction Yugan He, Yigang Tong
152 [GO] 2021―Jun―16 Comparison of Two Digital PCR Methods for EGFR DNA and SARS-CoV-2 RNA Quantification Sang-Soo Lee, Jae-Hyeong Park, Young-Kyung Bae
153 [GO] 2021―May―21 Combination of lymphocyte count and not the serological response with high-sensitivity cardiac troponin for risk stratification in patients with possible COVID-19 Saranya Kittanakom, Peter A Kavsak
154 [GO] 2021―May―03 ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors Jaroslav A. H뫎k, Ladislav Dusek, Ondrej Majek, Vaclav Adamek, Tereza Cervinkova, Dana Dlouha, Vera Adamkova
155 [GO] 2021―Apr―30 Clinical laboratory evaluation of COVID-19 Chen Zhufeng, Xu Wanju, Ma Wanshan, Shi Xiaohong, Li Shuomin, Hao Mingju, et al. (+2)
156 [GO] 2021―Apr―28 The Effect of the Covid-19 Shutdown on Glycemic Testing and Control Anu Sharma, Dina N. Greene, Allison B. Chambliss, Christopher W. Farnsworth, Deborah French, Daniel S. Herman, et al. (+9)
157 [GO] 2021―Apr―27 Evaluation of 32 rapid tests for detection of antibodies against SARS-CoV-2 Mette C. Tollånes, Pål A. Jenum, Helene Kierkegaard, Eirik Abildsnes, Roar Magne Bævre-Jensen, Anne C. Breivik, Sverre Sandberg
158 [GO] 2021―Apr―24 Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls Maribel Rodríguez-Aguilar, Lorena Díaz de León-Martínez, Blanca Nohemí Zamora-Mendoza, Andreu Comas-García, Sandra Elizabeth Guerra Palomares, Christian Alberto García-Sepúlveda, et al. (+3)
159 [GO] 2021―Apr―17 Methods Matter - Tailoring SARS-CoV-2 Antibody Targets to Vaccination Status Alexandra R. Rapp, John O. Ogunbileje, Diane Djouodo-Nemzou, Anthony O. Okorodudu
160 [GO] 2021―Apr―05 Clinical relevance of serum α-L-fucosidase activity in the SARS-CoV-2 infection En-yu Liang, Guo-hua Li, Wen-gong Wang, Xin-min Qiu, Pei-feng Ke, Min He, Xian-zhang Huang
161 [GO] 2021―Mar―17 Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: a method comparison of two different commercially available serological assays from the same manufacturer Thomas Mueller
162 [GO] 2021―Feb―24 Lipid metabolism changes in patients with severe COVID-19 Yi Li, Yan Zhang, Rongli Lu, Minhui Dai, Minxue Shen, Jianchu Zhang, et al. (+12)
163 [GO] 2021―Feb―22 Correlation of Krebs von den Lungen-6 and Fibronectin with pulmonary fibrosis in Coronavirus Disease 2019 Ding-Hui Peng, Yi Luo, Li-Jun Huang, Fan-Lu Liao, Yan-Yuan Liu, Peng Tang, et al. (+2)
164 [GO] 2021―Feb―21 Salivary SARS-CoV-2 antigen rapid detection: a prospective cohort study Daniela Basso, Ada Aita, Andrea Padoan, Chiara Cosma, Filippo Navaglia, Stefania Moz, et al. (+4)
165 [GO] 2021―Jan―22 rRT-PCR for SARS-CoV-2: analytical considerations Rezgar Rahbari, Nariman Moradi, Mohammad Abdi
166 [GO] 2020―Dec―13 Novel automated sample-to-result SARS-CoV-2 laboratory-developed RT-PCR assay for high-throughput testing using LabTurbo AIO 48 system Ming-Jr Jian, Hsing-Yi Chung, Chih-Kai Chang, Jung-Chung Lin, Kuo-Ming Yeh, Sheng-Kang Chiu, et al. (+7)
167 [GO] 2020―Dec―04 The impact of biosafety enhancement on stat laboratory quality metrics: lessons from the COVID-19 pandemic John L. Frater, Jeanne Anderson
168 [GO] 2020―Dec―04 A Nomogram to Early Predict Isolation Length for Non-severe COVID-19 Patients Based on Laboratory Investigation: A Multicenter Retrospective Study in Zhejiang Province, China Yan Xia, Yan Zhang, Shijin Yuan, Jiangnan Chen, Wei Zheng, Xiaoping Xu, et al. (+2)
169 [GO] 2020―Nov―22 Serum potassium concentrations in COVID-19 Dominika Szoke, Simone Caruso, Elena Aloisio, Sara Pasqualetti, Alberto Dolci, Mauro Panteghini
170 [GO] 2020―Nov―05 Biclonal gammopathay in a case of severe COVID-19 Pooja Vashistha, Ajay Gupta, Mona Arya, Vijay Kumar Singh, Abhishek Dubey, Bidhan Chandra Koner
171 [GO] 2020―Nov―05 Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases Johannes Wolf, Thorsten Kaiser, Sarah Pehnke, Olaf Nickel, Christoph Lübbert, Sven Kalbitz, et al. (+7)
172 [GO] 2020―Nov―05 Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications Yanfang Jiang, Haifeng Wang, Sijia Hao, Yukun Chen, Jiaxue He, Yong Liu, et al. (+3)
173 [GO] 2020―Oct―21 The N gene of SARS-CoV-2 was the main positive component in repositive samples from a cohort of COVID-19 patients in Wuhan, China Xuzhao Zhang, Min Li, Bin Zhang, Tao Chen, Dong Lv, Pengfei Xia, et al. (+5)
174 [GO] 2020―Oct―15 Hock-a-loogie saliva as a diagnostic specimen for SARS-CoV-2 by a PCR-based assay: a diagnostic validity study Jian Fan, Fei Yu, Xiang Wang, Qianda Zou, Bin Lou, Guoliang Xie, et al. (+15)
175 [GO] 2020―Oct―12 Positive control synthesis method for COVID-19 diagnosis by one-step real-time RT-PCR Hyejin Cho, Young Hwan Jung, Hong Bum Cho, Hee-tae Kim, Kwang-sun Kim
176 [GO] 2020―Oct―12 Evaluation of the clinical performance of single-, dual-, and triple-target SARS-CoV-2 RT-qPCR methods Xiaomei Hu, Lingxiang Zhu, Yijun Luo, Qinfei Zhao, Chianru Tan, Xiao Chen, et al. (+13)
177 [GO] 2020―Oct―01 Cardiac troponin I in SARS-CoV-2-patients: the additional prognostic value of serial monitoring Martina Zaninotto, Monica Maria Mion, Andrea Padoan, Luciano Babuin, Mario Plebani
178 [GO] 2020―Sep―29 SARS-CoV-2 infection serology validation of different methods: usefulness of IgA in the early phase of infection Massimo Pieri, Marco Ciotti, Nicoletta Carlozzi, Maria Loredana Frassanito, Arianna Meloni, Alessandro Cistera, et al. (+5)
179 [GO] 2020―Sep―19 Clinical Performance of A Semi-Quantitative Assay for SARS-CoV2 IgG and SARS-CoV2 IgM Antibodies Joanna Jung, Emily Garnett, Purviben Jariwala, Hue Pham, Rongrong Huang, Eduardo Benzi, et al. (+4)
180 [GO] 2020―Sep―16 SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis Ada Aita, Daniela Basso, Anna Maria Cattelan, Paola Fioretto, Filippo Navaglia, Francesco Barbaro, et al. (+6)
181 [GO] 2020―Sep―15 Update on Serologic Testing in COVID-19 Rafał Krajewski, Justyna Gołębiowska, Sebastian Makuch, Grzegorz Mazur, Siddarth Agrawal
182 [GO] 2020―Sep―08 Saliva for use with a point of care assay for the rapid diagnosis of COVID-19 Jeffrey A. SoRelle, Lenin Mahimainathan, Clare McCormick-Baw, Dominick Cavuoti, Francesca Lee, Abey Thomas, et al. (+3)
183 [GO] 2020―Sep―08 Performance of an automated chemiluminescence SARS-COV-2 IG-G Assay C.S. Lau, H.M.L. Oh, S.P. Hoo, Y.L. Liang, S.K. Phua, T.C. Aw
184 [GO] 2020―Aug―25 Comparison of qualitative and quantitative analyses of COVID-19 clinical samples Yan Dang, Ning Liu, Chianru Tan, Yingmei Feng, Xingxing Yuan, Dongdong Fan, et al. (+4)
185 [GO] 2020―Aug―18 Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity Andrea Padoan, Francesco Bonfante, Silvia Zuin, Chiara Cosma, Daniela Basso, Mario Plebani
186 [GO] 2020―Aug―14 Laboratory Findings in COVID-19 Diagnosis and Prognosis Atieh Pourbagheri-Sigaroodi, Davood Bashash, Fatemeh Fateh, Hassan Abolghasemi
187 [GO] 2020―Aug―12 Potential diagnostics and therapeutic approaches in COVID-19 Pratibha Kumari, Archana Singh, Moses Rinchui Ngasainao, Ilma Shakeel, Sanjay Kumar, Seema Lal, et al. (+4)
188 [GO] 2020―Aug―10 ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population Abhijit Pati, Harishankar Mahto, Sunali Padhi, Aditya K Panda
189 [GO] 2020―Aug―07 Ethical and organizational considerations for mandatory COVID-19 vaccination of health care workers: a clinical laboratorian's perspective Raffick A.R. Bowen
190 [GO] 2020―Jul―24 COVID-19 infection and Thrombosis Swati Srivastava, Iti Garg, Anju Bansal, Bhuvnesh Kumar
191 [GO] 2020―Jul―16 The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19 Pingji Deng, Zunqiong Ke, Binwu Ying, Bin Qiao, Leyong Yuan
192 [GO] 2020―Jul―16 SARS-CoV-2 and the cardiovascular system Anouar Hafiane
193 [GO] 2020―Jul―14 Insights into pediatric multi-system inflammatory syndrome and COVID-19 David Bar-Or, Leonard T. Rael, Edward N. Brody
194 [GO] 2020―Jul―11 COVID-19: review and hematologic impact Sílvia Letícia de Oliveira Toledo, Leilismara Sousa Nogueira, Maria das Graças Carvalho, Danyelle Romana Alves Rios, Melina de Barros Pinheiro
195 [GO] 2020―Jul―10 Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection Xingzhong Hu, Dong Chen, Lianpeng Wu, Guiqing He, Wei Ye
196 [GO] 2020―Jul―10 CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation Aditya K. Panda, Archana Padhi, B. Anjan Kumar Prusty
197 [GO] 2020―Jul―07 Time-dependent changes in the clinical characteristics and prognosis of hospitalized COVID-19 patients in Wuhan, China: A retrospective study Menglong Wang, Jishou Zhang, Di Ye, Zhen Wang, Jianfang Liu, Hua He, et al. (+12)
198 [GO] 2020―Jul―07 Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU Dong Zhang, Xiang Zhou, Songxin Yan, Ran Tian, Longxiang Su, Xin Ding, et al. (+11)
199 [GO] 2020―Jul―02 Laboratory Diagnosis of Coronavirus Disease-2019 (COVID-19) Chenxi Li, Chengxue Zhao, Jingfeng Bao, Bo Tang, Yunfeng Wang, Bing Gu
200 [GO] 2020―Jun―27 Less expression of CD4+ and CD8+ T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: evidence from a pooled analysis Daojun Hu, Li Li, Wenjie Shi, Li Zhang
201 [GO] 2020―Jun―21 Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator? Jenifer Gómez-Pastora, Mitchell Weigand, James Kim, Xian Wu, Jacob Strayer, Andre F. Palmer, et al. (+3)
202 [GO] 2020―Jun―20 Impact of Heat-Inactivation on the detection of SARS-CoV-2 IgM and IgG Antibody by ELISA Xiumei Hu, Ruyi Zhang, Taixue An, Qiang Li, Bo Situ, Zihao Ou, et al. (+7)
203 [GO] 2020―Jun―17 Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19 Yuqin Wu, Zhicai Feng, Peng Li, Qizhi Yu
204 [GO] 2020―Jun―16 Cautious interpretation of antiphospholipid antibodies in COVID-19 Sudhir Mehta, Sudhir Bhandari, Shaurya Mehta
205 [GO] 2020―Jun―11 Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis Takayuki Yamada, Mako Wakabayashi, Takahiro Yamaji, Nitin Chopra, Takahisa Mikami, Hirotaka Miyashita, Satoshi Miyashita
206 [GO] 2020―Jun―10 Cytokine Storm Induced by SARS-CoV-2 Peipei Song, Wei Li, Jianqin Xie, Yanlong Hou, Chongge You
207 [GO] 2020―Jun―09 Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients Poggiali Erika, Zaino Domenica, Immovilli Paolo, Rovero Luca, Losi Giulia, Dacrema Alessandro, et al. (+7)
208 [GO] 2020―Jun―08 Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma Christian Bundschuh, Margot Egger, Kurt Wiesinger, Christian Gabriel, Martin Clodi, Thomas Mueller, Benjamin Dieplinger
209 [GO] 2020―Jun―06 Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19 Jingfeng Bao, Chenxi Li, Kai Zhang, Haiquan Kang, Wensen Chen, Bing Gu
210 [GO] 2020―Jun―05 C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection Bikash R Sahu, Raj Kishor Kampa, Archana Padhi, Aditya K. Panda
211 [GO] 2020―Jun―04 SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays He Sarina Yang, Sabrina E. Racine-Brzostek, William T. Lee, Danielle Hunt, Jim Yee, Zhengming Chen, et al. (+11)
212 [GO] 2020―Jun―03 Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator Agostino Ognibene, Maria Lorubbio, Pasqualino Magliocca, Emanuela Tripodo, Guendalina Vaggelli, Giovanni Iannelli, et al. (+6)
213 [GO] 2020―May―30 Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDITM enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma Margot Egger, Christian Bundschuh, Kurt Wiesinger, Christian Gabriel, Martin Clodi, Thomas Mueller, Benjamin Dieplinger
214 [GO] 2020―May―30 Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? Mario Plebani, Andrea Padoan, Davide Negrini, Benedetta Carpinteri, Laura Sciacovelli
215 [GO] 2020―May―29 COVID-19: Transmission, prevention, and potential therapeutic opportunities Melika Lotfi, Michael R. Hamblin, Nima Rezaei
216 [GO] 2020―May―23 An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19 Mostafa Saadat
217 [GO] 2020―May―14 The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: a sentinel? Da-wei Sun, Dong Zhang, Run-hui Tian, Yang Li, Yu-shi Wang, Jie Cao, et al. (+9)
218 [GO] 2020―May―13 Decreased T cell populations contribute to the increased severity of COVID-19 Rui Liu, Ying Wang, Jie Li, Huan Han, Zunen Xia, Fang Liu, et al. (+4)
219 [GO] 2020―May―13 Dynamic changes in routine blood parameters of a severe COVID-19 case Guoguang Lu, Jing Wang
220 [GO] 2020―May―05 Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences András Zóka, Gabriella Bekő
221 [GO] 2020―Apr―27 IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study Andrea Padoan, Laura Sciacovelli, Daniela Basso, Davide Negrini, Silvia Zuin, Chiara Cosma, et al. (+3)
222 [GO] 2020―Apr―27 Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis Brandon Michael Henry, Jens Vikse, Stefanie Benoit, Emmanuel J. Favaloro, Giuseppe Lippi
223 [GO] 2020―Apr―24 Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China Suyu Sun, Xuejiao Cai, Huaguo Wang, Guiqing He, Yin Lin, Bibi Lu, et al. (+3)
224 [GO] 2020―Apr―23 Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories Takayuki Ishige, Shota Murata, Toshibumi Taniguchi, Akiko Miyabe, Kouichi Kitamura, Kenji Kawasaki, et al. (+3)
225 [GO] 2020―Apr―22 Presepsin in risk stratification of SARS-CoV-2 patients Martina Zaninotto, Monica Maria Mion, Chiara Cosma, Daniela Rinaldi, Mario Plebani
226 [GO] 2020―Apr―18 Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients Hu Yun, Zhuoran Sun, Jun Wu, Aiguo Tang, Min Hu, Zhongyuan Xiang
227 [GO] 2020―Mar―28 Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient Ding-feng Lv, Qi-ming Ying, Yue-song Weng, Chi-bin Shen, Jin-guo Chu, Jing-ping Kong, et al. (+4)
228 [GO] 2020―Mar―24 The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections Joris R Delanghe, Marijn M Speeckaert, Marc L De Buyzere
229 [GO] 2020―Mar―13 Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis Giuseppe Lippi, Mario Plebani, Brandon Michael Henry
230 [GO] 2020―Mar―07 Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 Rui Liu, Huan Han, Fang Liu, Zhihua Lv, Kailang Wu, Yingle Liu, et al. (+2)
231 [GO] 2020―Mar―04 Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis Giuseppe Lippi, Mario Plebani
 [1] 

231 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec